Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04194619

Pregnancy in Women With Rare Multisystemic Vascular Diseases: COGRare5 Study

A National Prospective Cohort for Pregnancies in Patients With Rare Vascular Anomalies: COGRare5 Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

There are no prospective studies of pregnancies for the diseases studied here in (Heredity Hemorrhagic Telangiectasia, Marfan syndrome or related, primary lower limb lymphedema, superficial arteriovenous malformations, and cerebro-spinal arteriovenous malformations) although complications of these can present life-threatening health problems for the mother and her baby. The purpose of this National prospective study is to obtain greater insight into obstetrical complications associated with rare maternal vascular genetic disorders in order to improve prevention and to reduce risk of death. In this context, experts and patient associations consider that there is a need to make real progress in the formulation of recommendations based on scientific data.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaireInterview of women with a rare vascular disease through a phone questionnaire about severe and specific obstetrical complications during and after pregnancy.

Timeline

Start date
2020-02-06
Primary completion
2027-02-01
Completion
2028-11-01
First posted
2019-12-11
Last updated
2026-03-11

Locations

36 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04194619. Inclusion in this directory is not an endorsement.